Patents by Inventor Junkun PAN

Junkun PAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition containing hesperetin and synergistic hypoglycemic application thereof
    Patent number: 11771679
    Abstract: The present invention discloses a composition containing hesperetin and synergistic hypoglycemic application thereof, and belongs to the technical field of natural active compounds. The composition of the present invention contains the hesperetin and a compound X, and the compound X is galangin or formononetin, where a mass ratio of the hesperetin to the galangin is 30:100, and a mass ratio of the hesperetin to the formononetin is 30:20. The composition of the present invention has an obvious synergistic effect of inhibiting ?-glucosidase, and the effect thereof is better than that of using the flavonoid compound alone, and may reduce a dosage of the use of drugs and occurrence of drug resistance.
    Type: Grant
    Filed: December 15, 2022
    Date of Patent: October 3, 2023
    Assignee: ZHENGZHOU FRUIT RESEARCH INSTITUTE, CHINESE ACADEMY OF AGRICULTURAL SCIENCES
    Inventors: Qiang Zhang, Zhonggao Jiao, Dalei Chen, Jiechao Liu, Wenbo Yang, Chunling Zhang, Hui Liu, Zhenzhen Lv, Junkun Pan
  • Composition for inhibiting alpha-glucosidase and application thereof
    Patent number: 11753388
    Abstract: The present invention discloses a composition for inhibiting ?-glucosidase and application thereof, and belongs to the technical field of natural active compounds. The composition of the present invention contains daidzein and quercetin derivatives, and the quercetin derivative is taxifolin or 3-O-methyl quercetin, where the mass ratio of the daidzein to the taxifolin is 8:25-10:25; and the mass ratio of the daidzein to the 3-O-methyl quercetin is 8:2-8:4. The composition of the present invention has an obvious synergistic effect of inhibiting ?-glucosidase, and the effect thereof is better than that of using the flavonoid compound alone, and may reduce a dosage of the use of drugs and occurrence of drug resistance.
    Type: Grant
    Filed: December 15, 2022
    Date of Patent: September 12, 2023
    Assignee: ZHENGZHOU FRUIT RESEARCH INSTITUTE, CHINESE ACADEMY OF AGRICULTURAL SCIENCES
    Inventors: Jiechao Liu, Qiang Zhang, Zhonggao Jiao, Dalei Chen, Junkun Pan, Chunling Zhang, Hui Liu, Wenbo Yang, Zhenzhen Lv
  • COMPOSITION CONTAINING HESPERETIN AND SYNERGISTIC HYPOGLYCEMIC APPLICATION THEREOF
    Publication number: 20230125518
    Abstract: The present invention discloses a composition containing hesperetin and synergistic hypoglycemic application thereof, and belongs to the technical field of natural active compounds. The composition of the present invention contains the hesperetin and a compound X, and the compound X is galangin or formononetin, where a mass ratio of the hesperetin to the galangin is 30:100, and a mass ratio of the hesperetin to the formononetin is 30:20. The composition of the present invention has an obvious synergistic effect of inhibiting ?-glucosidase, and the effect thereof is better than that of using the flavonoid compound alone, and may reduce a dosage of the use of drugs and occurrence of drug resistance.
    Type: Application
    Filed: December 15, 2022
    Publication date: April 27, 2023
    Inventors: Qiang ZHANG, Zhonggao JIAO, Dalei CHEN, Jiechao LIU, Wenbo YANG, Chunling ZHANG, Hui LIU, Zhenzhen LV, Junkun PAN
  • COMPOSITION FOR INHIBITING ALPHA-GLUCOSIDASE AND APPLICATION THEREOF
    Publication number: 20230129488
    Abstract: The present invention discloses a composition for inhibiting ?-glucosidase and application thereof, and belongs to the technical field of natural active compounds. The composition of the present invention contains daidzein and quercetin derivatives, and the quercetin derivative is taxifolin or 3-O-methyl quercetin, where the mass ratio of the daidzein to the taxifolin is 8:25-10:25; and the mass ratio of the daidzein to the 3-O-methyl quercetin is 8:2-8:4. The composition of the present invention has an obvious synergistic effect of inhibiting ?-glucosidase, and the effect thereof is better than that of using the flavonoid compound alone, and may reduce a dosage of the use of drugs and occurrence of drug resistance.
    Type: Application
    Filed: December 15, 2022
    Publication date: April 27, 2023
    Inventors: Jiechao LIU, Qiang ZHANG, Zhonggao JIAO, Dalei CHEN, Junkun PAN, Chunling ZHANG, Hui LIU, Wenbo YANG, Zhenzhen LV